Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
   Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
   
  
  July 30, 2024
  From CNBC.com News
 From CNBC.com News
 
   Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
   
  
  July 25, 2024
  From CNBC.com News
 
   Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
   
  
  July 25, 2024
  From CNBC.com News
 
   Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
   
  
  July 23, 2024
  From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 Tickers 
   LAWS
  
  
  From CNBC.com News
 
   CNBC Daily Open: French far-right advance blocked
   
  
  July 07, 2024
  From CNBC.com News
 From CNBC.com News
 
   Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
   
  
  July 04, 2024
  From CNBC.com News
 
   Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
   
  
  July 03, 2024
  From CNBC.com News
 
   Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
   
  
  June 26, 2024
  From CNBC.com News
 
   5 things to know before the stock market opens
   
  
  June 25, 2024
  From CNBC.com News
 
   Novo Nordisk's Wegovy weight loss drug approved in China
   
  
  June 25, 2024
  From CNBC.com News
 
   Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
   
  
  June 24, 2024
  From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 
   How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
   
  
  June 17, 2024
  From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 
   Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
   
  
  May 29, 2024
  From CNBC.com News
 
   Cramer's Lightning Round: Apple is a buy
   
  
  May 28, 2024
  From CNBC.com News
 From CNBC.com News
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
